Nuo Therapeutics, Inc.
AURX
$1.24
$0.010.78%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 142.69% | 123.71% | 89.63% | 106.53% | 124.37% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 142.69% | 123.71% | 89.63% | 106.53% | 124.37% |
| Cost of Revenue | 261.82% | 200.04% | 121.36% | 124.41% | 140.13% |
| Gross Profit | 108.80% | 102.13% | 81.45% | 101.67% | 120.21% |
| SG&A Expenses | 34.50% | 29.92% | 16.42% | 2.67% | -3.58% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 52.50% | 41.94% | 22.37% | 8.00% | 1.22% |
| Operating Income | -2.39% | -3.45% | 3.31% | 17.49% | 22.43% |
| Income Before Tax | -8.11% | 2.01% | 8.24% | 21.93% | 26.73% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -8.11% | 2.01% | 8.24% | 21.93% | 26.73% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -8.11% | 2.01% | 8.24% | 21.93% | 26.73% |
| EBIT | -2.39% | -3.45% | 3.31% | 17.49% | 22.43% |
| EBITDA | 0.15% | -1.14% | 4.78% | 18.23% | 22.78% |
| EPS Basic | -3.51% | 8.02% | 14.79% | 27.89% | 32.05% |
| Normalized Basic EPS | 1.77% | 2.56% | 10.03% | 23.48% | 28.03% |
| EPS Diluted | -3.51% | 8.02% | 14.79% | 27.89% | 32.05% |
| Normalized Diluted EPS | 1.77% | 2.56% | 10.03% | 23.48% | 28.03% |
| Average Basic Shares Outstanding | 4.16% | 6.37% | 7.38% | 7.91% | 7.95% |
| Average Diluted Shares Outstanding | 4.16% | 6.37% | 7.38% | 7.91% | 7.95% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |